Find Academic Supervisors

Michele ZagnoniView profile

Associate Professor

• Microfluidics
• Lab-on-a-chip
• Bioelectronics
• +4 more

Dr. Michele Zagnoni is a Reader (equivalent to Associate Professor) in the Department of Electronic & Electrical Engineering at the University of Strathclyde, Glasgow, UK. He leads the Zagnoni Lab, which focuses on developing microfluidic and lab-on-a-chip technologies for healthcare applications including fundamental biological research, drug screening, and personalized medicine therapy. His research group works on creating organ-on-a-chip in vitro models and synthetic biology applications. His academic qualifications include: Ph.D. degree in Electronic Engineering and Computer Science (2006) Dr. Eng. degree (5 year degree) in Electronic Engineering with Bioengineering qualification (2002) Italian state certification for engineering practice (2002) PostGraduate Certificate in Advanced Academic Studies (2012) Member of the EPSRC Peer Review College (2013) Dr. Zagnoni's research spans microfluidic technology development for healthcare applications with particular emphasis on: Development of microsystems for basic biology investigation Diagnosis and treatment of disease Creation of in vitro models and organ-on-a-chip systems Synthetic biology applications High-throughput screening and diagnostic systems His recent publications (2020-2025) demonstrate a strong trend toward neurological disease modeling, cancer research, and reproductive health applications using microfluidic platforms. His work bridges fundamental microfluidic technology development with applied healthcare solutions, with increasing focus on patient-derived models and precision medicine approaches for conditions including Parkinson's disease, Alzheimer's disease, cancer, and stroke. Scientific recognition includes: Member of Departmental Safety Committee (2011) Dr. Zagnoni actively supervises students and has secured numerous research grants, including major projects funded by EPSRC and the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs). His lab has developed innovative microfluidic platforms for drug screening, disease modeling, and diagnostic applications. Current research projects include developing human stroke-on-a-chip models, engineering the bone marrow niche to control stem cell regulation, and creating microfluidic platforms for immuno-oncology drug screening services. The Zagnoni Lab operates from the Technology and Innovation Centre at the University of Strathclyde and collaborates extensively with biotech and pharmaceutical industries. The lab has also spun out ScreenIn3D, a start-up company providing miniaturized oncology drug screening services using 3D human in vitro models of disease.

Andrew V. OleinikovView profile

Professor

• Malaria pathogenesis
• Placental malaria
• PfEMP1 biology
• +7 more

Andrew V. Oleinikov, Ph.D. , is a full Professor of Biomedical Science at the Charles E. Schmidt College of Medicine, Florida Atlantic University . Since 2013 he has held a continuous academic appointment, receiving tenure in 2017 and promotion to full professor in 2019. Education M.S. (hons) in Biophysics, St. Petersburg Polytechnical University, Russia, 1983 Ph.D. in Biology, Moscow State University, Russia, 1989 Research Focus Oleinikov’s laboratory integrates molecular parasitology with bioengineering to study Plasmodium falciparum . He investigates how parasite surface proteins—especially the PfEMP1/VAR2CSA family—mediate cytoadherence in placental malaria, aiming to develop vaccines and anti-adhesion drugs. Parallel efforts include building placenta-on-a-chip microfluidic devices and high-throughput screening platforms to accelerate discovery. Earlier work elucidated the role of the endocytic receptor megalin and its adaptor Dab2 in signal transduction, providing foundational insights into receptor-mediated endocytosis. Publication Trends Over the past decade his papers cluster around three themes: (1) functional dissection of PfEMP1 domains and their receptors (ICAM-1, CSA, integrins); (2) translational development of vaccines and small-molecule anti-sequestration agents; and (3) technological innovations—microfluidics, biosensors, and ultra-sensitive molecular diagnostics—for malaria research and placental health. Scientific Awards & Honors FAU Researcher of the Year Award (Associate Professor category), 2018 FAU Degree of Difference Award for graduate teaching, 2015 Faculty Research Mentoring Program Award, 2015 & 2016 Grants & Team Mentorship Oleinikov’s research is continuously funded by NIH (multiple R01, R21, R41) and the Bill & Melinda Gates Foundation. He mentors graduate and undergraduate researchers, many of whom have garnered FAU GRIP grants, 1st-place conference awards, and College of Medicine Student Research Awards. Laboratory & Collaborations He directs an active wet-lab/bioengineering group housed in the Biomedical Science department. Ongoing collaborations include co-investigators in the FAU College of Engineering (Drs. Du and Yi) for microfluidic device fabrication and with international consortia on pregnancy malaria vaccines.

Ingrid FritschView profile

Professor

• Analytical Chemistry
• Electrochemistry
• Microfluidics
• +3 more

Dr. Ingrid Fritsch is a Professor of Analytical Chemistry in the Department of Chemistry and Biochemistry at the University of Arkansas, College of Arts & Sciences. She has pioneered the field of redox-magnetohydrodynamic microfluidics and developed multifunctional miniaturized analytical devices and sensors, including protein and DNA-hybridization microarrays interfaced to electrochemical detection. Her work is critical for developing portable devices for environmental and point-of-care chemical analysis. Education: B.S. in Chemistry, University of Utah, Salt Lake City Ph.D. in Chemistry, University of Illinois at Urbana-Champaign Postdoctoral Associate, Massachusetts Institute of Technology Dr. Fritsch's research focuses on the development of multifunctional, miniaturized analytical devices with integrated components on a single substrate. She pioneered the field of redox-magnetohydrodynamic (R-MHD) microfluidics, which applies astrophysical plasma principles to analytical chemistry. Her innovative approach enables picoliter-scale stirring, solution movement across chips for processing, and solvent forcing through channels for mixture separations. Her work spans ultrasmall volume analysis, novel microelectrode geometries, neurotransmitter differentiation via electrochemical methods, and interfacing micro/nano-scale electrochemistry with immunoassays and DNA-hybridization assays. Analysis of her recent publications reveals strong continuity in her research focus on redox-magnetohydrodynamics, with increasing sophistication in applications to biological systems, nanoparticle characterization, and neural analysis. Her group has expanded from fundamental fluid manipulation to specialized applications in neurotransmitter detection, cytometry, and bioelectronic interfaces. Scientific Awards: Society of Electroanalytical Chemistry Young Investigator Award (1997) National Science Foundation Career Award NSF Special Creativity Extension American Chemical Society Chemistry Ambassador (2013-2015) Fellow of the National Academy of Inventors (2014) University of Arkansas Golden Tusk Award (2015) Fellow of the American Association for the Advancement of Science (2015) University of Arkansas Alumni Distinguished Faculty Award in Research (2016) Dr. Fritsch has secured significant research funding including an NSF Career Award and Special Creativity Extension. She has co-founded two startup companies and holds ten issued U.S. patents, demonstrating strong translational impact. Her teaching spans undergraduate and graduate levels, with extensive outreach to middle and high school students. She has taught courses ranging from Chemistry I for Majors to specialized graduate courses in Electrochemical Methods of Analysis and Energy Conversion and Storage. Her research group investigates chemistry at ultrasmall volumes with materials having ultrasmall features, developing innovative approaches to solution movement for automated sequential reactions. They have made seminal contributions to redox-magnetohydrodynamics, creating methods for picoliter-scale stirring and channel-free fluid manipulation within microfluidic devices.

Peter H. SeebergerView profile

Professor

• Glycosciences
• Carbohydrate Chemistry
• Vaccine Development
• +3 more

Peter H. Seeberger is Director at the Max-Planck Institute for Colloids and Surfaces in Potsdam, Professor at the Freie Universität Berlin, and honorary Professor at Potsdam University. He previously served as Affiliate Professor at the Sanford-Burnham Institute for Medical Research (2003-2014) and Professor at ETH Zurich. Since 2021, he has been Vice President of the German Research Foundation (DFG), and since 2023 has served as Founding Director of the Center for the Transformation of Chemistry with €1.25 billion funding. His research spans glycosciences, carbohydrate chemistry, vaccine development, and continuous flow synthesis. Seeberger developed the chemical basis for automated glycan assembly, enabling the synthesis of complex polysaccharides up to 100-mers. His work has opened new pathways for synthetic glycoconjugate vaccines against pathogens including Streptococcus pneumoniae, Clostridium difficile, and Klebsiella pneumoniae. He also pioneered continuous photochemical processes for artemisinin production to combat malaria. Seeberger's recent publications reveal a strong trend toward applying glycobiology to vaccine development, diagnostics, and nanotechnology. His work increasingly focuses on translating basic research into clinical applications, with several vaccine candidates in human trials. The integration of continuous flow chemistry with glycan synthesis represents a major technological advancement in his field. ACS Award for Affordable Green Chemistry (2021) Stifterverband Science Prize (2017) Körber European Science Award (2007) Arthur C. Cope Young Scholar Award (2003) Elected to Berlin-Brandenburg Academy of Sciences (2013) Over 40 international awards total Seeberger's laboratory has produced over 690 peer-reviewed articles, 5 books, and 60+ patent families. His research has spawned multiple spin-off companies including Vaxxilon AG (acquired by Idorsia), Tacalyx, ArtemiFlow, and GlycoUniverse. As editor of the Beilstein Journal for Organic Chemistry since 2009, he promotes open access publishing. His work on the Center for the Transformation of Chemistry represents a major funding initiative to reshape chemical research and industry. Seeberger leads the Biomolecular Systems department at the Max Planck Institute, which includes research groups focused on automated glycan assembly, glycoconjugate vaccine development, and continuous flow synthesis. His Center for the Transformation of Chemistry represents a major collaborative effort across German research institutions with significant government funding.

• Cytogenetics
• Genetic Disorders
• Prenatal Diagnosis
• +3 more

Jia Di Wen, MD, PhD, FACMG is an Assistant Professor in the Department of Genetics and Assistant Director of the Clinical Cytogenetics Laboratory at Yale School of Medicine. She holds dual appointments in the Genetics department and collaborates extensively with researchers in reproductive medicine and genomic diagnostics. Education: MD from Capital Medical University (1993), PhD in Reproductive and Developmental Sciences from University of British Columbia (2010). Research focuses on cytogenetic and genomic mechanisms underlying pregnancy loss, chromosomal abnormalities, and genetic disorders. Her work emphasizes translational applications in prenatal diagnosis, including microarray analysis of products of conception, exome sequencing for fetal anomalies, and characterization of ring chromosomes in congenital disorders. Key areas include genomic instability in tumors, haploinsufficiency syndromes, and validation of diagnostic platforms like OncoScan and oligonucleotide arrays. Key contributions include meta-analyses of pregnancy loss etiologies, genotype-phenotype correlations in chromosomal deletions, and improving diagnostic accuracy through homozygosity mapping. Her clinical role supports both prenatal and pediatric genetic testing, integrating advanced cytogenomic techniques into patient care. Laboratory activities involve the Clinical Cytogenetics Lab, focusing on diagnostic applications of genomic technologies. Active collaborations exist with investigators like Dr. Peining Li, Allen Bale, and Yong-Hui Jiang in genetic disease mechanisms and clinical diagnostics.

Kevin LinView profile

Assistant Professor

• Single-cell Biology
• Statistical Genetics
• Biostatistics
• +3 more

Kevin Lin is an Assistant Professor in the Department of Biostatistics at the University of Washington, joining in Fall 2023. His research focuses on developing statistical methods for analyzing single-cell data to uncover cellular mechanisms in diseases like Alzheimer’s and immune resistance. He holds a PhD from Carnegie Mellon University and completed postdoctoral training at the University of Pennsylvania. His work bridges computational methods with biological questions, emphasizing matrix factorization, network modeling, and changepoint detection. Education: PhD in Statistics & Data Science (Carnegie Mellon University, 2020) Previous Role: Postdoctoral Researcher at University of Pennsylvania (Wharton Statistics) Research interests include high-dimensional data analysis, statistical genetics, and single-cell RNA-Seq. Notable contributions include methods like Tilted-CCA for multimodal data integration and eSVD-DE for cohort-wide differential expression analysis. His work has been recognized with awards such as the Wikimedia Foundation Research Award (2023). Lin’s lab collaborates on projects involving endolysosomal dysfunction in Alzheimer’s, yeast cell division dynamics, and lineage-aware machine learning. Key achievements include over 20 publications in journals like Nature Biotechnology , PNAS , and Biometrics . He advises on grants related to single-cell technologies and serves on the EDI subcommittee for mental health initiatives at UW. Outside academia, Lin enjoys zumba and cooking.

Kristoffer Vitting-SeerupView profile

Associate Professor

• Bioinformatics
• Computational Biology
• Transcriptomics
• +5 more

Kristoffer Vitting-Seerup is an Associate Professor at the Department of Health Technology , Technical University of Denmark, specializing in Bioinformatics and Isoform Analysis . His research focuses on leveraging RNA sequencing, alternative splicing, and protein domain variants to advance cancer genomics and neuro-oncology. Current academic rank: Associate Professor Key collaborations: DTU, University of Copenhagen, international cancer research teams Supervisory role: 5 PhD students in projects spanning machine learning for single-cell sequencing and isoform-level systems biology His work demonstrates strong emphasis on transcriptomics in glioblastoma, with recent publications analyzing tumor infiltration, neurodevelopmental pathways, and therapy resistance mechanisms. Articles reveal expertise in alternative splicing's role in biological signaling, protein domain functional diversity, and genomic stability in cancer stem cells. Research tools developed include satuRn for transcript usage analysis and IsoformSwitchAnalyzeR for splicing variant characterization. Current projects aim to improve clinical diagnostics through machine learning frameworks and enhance understanding of isoform-level biology in diseases. Advising: Rasmussen, M. N. (PhD Student, 2025-2028) Zhen, Z. T. (PhD Student, 2024-2027) Hsieh, C.-Y. (PhD Student, 2024-2027) Kanakoglou, D. S. (PhD Student, 2023-2026) Dam, S. H. (PhD Student, 2021-2025)

Mairi SandisonView profile

Senior Lecturer

• Biomedical Engineering
• Microfluidics
• Tissue Engineering
• +6 more

Dr. Mairi Sandison is a Senior Lecturer in Biomedical Engineering at the University of Strathclyde's Faculty of Engineering, United Kingdom. Her research focuses on advanced biomedical engineering applications with a particular emphasis on microfluidic systems , vascular tissue modeling , and cellular microarray technologies . She has developed innovative organ-on-a-chip models for studying uterine wall physiology and vascular aging, while also pioneering 3D-printed biomimetic microvasculature for ultrasound research. Her laboratory work has produced significant advancements in: Phenotypic heterogeneity analysis of vascular smooth muscle cells Microbubble acoustic backscattering measurement techniques Antimicrobial surface engineering using metal oxide-doped elastomers Cell preservation methods for single-cell analysis Biofilm formation dynamics in polymicrobial environments

Ross PorterView profile

Research Fellow

• Inflammatory Bowel Disease
• Colorectal Cancer
• Gastroenterology
• +4 more

Dr Ross Porter serves as a CRUK TRACC Clinical Research Training Fellow within the School of Cancer Sciences at the University of Glasgow, focusing on the intersection of inflammatory bowel disease (IBD) and gastrointestinal oncology. His research integrates clinical practice with translational science to address critical gaps in colorectal cancer surveillance and biomarker development for IBD patients. Porter's research interests center on Inflammatory Bowel Disease-associated colorectal carcinogenesis , with specific expertise in MLH1-deficient cancers , HMGB1 biomarker expression , and immune microenvironment characterization . His work leverages advanced methodologies including QuPath digital pathology algorithms , human tissue-derived organoid models , and immunohistochemical profiling to identify clinically actionable biomarkers for risk stratification and therapeutic targeting. Analysis of Porter's publication trends reveals a consistent focus on translational GI oncology , with 75% of his recent work examining IBD-cancer connections. Key themes include biomarker validation (HMGB1, c-MET, LL-37), endoscopic surveillance optimization, and organoid-based disease modeling. His research demonstrates strong clinical applicability, particularly in refining surveillance protocols for high-risk IBD populations. CRUK TRACC Clinical Research Training Fellowship Cancer Research UK Training Fellowship Porter's research is primarily funded through his CRUK fellowship, which supports his investigation into molecular mechanisms linking chronic inflammation to neoplastic progression. His collaborative work spans multiple institutions across Europe, with significant contributions to multicenter studies like the PORCSE Study on Crohn's disease recurrence. Current projects focus on developing digital pathology tools for automated cancer detection in IBD patients and characterizing immune-cold phenotypes in colorectal cancer. Porter actively collaborates with the Glasgow Cancer Research UK Centre and participates in tissue-based research using organoid models derived from patient samples. His work interfaces with clinical endoscopy units and pathology departments to validate biomarkers in real-world settings, emphasizing rapid translation from bench to bedside.

William R. SukovView profile

Physician Scientist

• Pathology
• Molecular Genetics
• Cytogenetics
• +3 more

William R. Sukov, M.D. is a Medical Geneticist and Pathologist at Mayo Clinic in Rochester, Minnesota, specializing in Laboratory Medicine and Pathology with a focus on Anatomic Pathology. He is affiliated with the Department of Laboratory Medicine and Pathology within the Mayo Clinic College of Medicine and Science. Dr. Sukov received his medical degree from the University of Colorado Health Sciences Center in 2004 and completed his undergraduate studies in Molecular, Cellular and Developmental Biology at the University of Colorado at Boulder in 1998. His training includes residencies and fellowships in Anatomic and Clinical Pathology, Surgical Pathology, and Cytogenetics at Mayo Clinic. His research interests center on molecular pathology, cytogenetics, and cancer diagnostics, with particular expertise in renal cell carcinoma, sarcoma diagnostics, and genomic profiling techniques. Dr. Sukov has made significant contributions to the understanding of TFE3/TFEB alterations in renal tumors, SNP chromosomal microarray applications, and molecular classification of various neoplasms. Analysis of his most recent publications reveals a strong focus on applying advanced genomic techniques to diagnostic pathology, particularly in renal tumors, sarcomas, and gynecologic neoplasms. His work bridges molecular diagnostics with clinical pathology, emphasizing practical applications of genomic technologies in everyday diagnostic settings. Dr. Sukov serves on multiple committees including the Quality Committee for the Division of Laboratory Genetics and Genomics and the CAP/ACMG Cytogenetics Resource Committee. He is an active member of several professional organizations including the American Society of Clinical Pathology, Association of Molecular Pathology, and College of American Pathologists. His laboratory work focuses on implementing advanced genomic technologies for diagnostic pathology, with particular emphasis on fluorescence in situ hybridization, next-generation sequencing, and chromosomal microarray analysis for tumor classification and diagnosis.

• Bacteriophage Mechanisms
• DNA Translocation
• Phage Evolutionary Genetics
• +2 more

Ian J. Molineux is Professor of Molecular Biosciences at the University of Texas at Austin, where he leads research on bacteriophage infection mechanisms using phage T7 as a model system. His work combines genetics, biophysics, and structural biology to understand DNA translocation across cell envelopes and develop phage-based applications. The Molineux lab focuses on: 1) Motor protein-driven DNA transport during phage infection, 2) Evolutionary genetics of phage-host interactions, and 3) Phage therapy development. Research employs CRISPR technology, electron cryo-tomography, and in vitro reconstitution approaches to study nucleic acid translocation mechanisms. Key discoveries include characterization of the phage DNA injection apparatus and demonstration of transcription-driven genome internalization. Recent work explores phage engineering for therapeutic applications and fundamental studies of host-parasite coevolution. Molineux teaches courses in molecular genetics and mentors graduate students in interdisciplinary virology research.

• Systems Biology
• Bioinformatics
• Computational Biology
• +9 more

Mario Lauria is an Associate Professor at the Department of Mathematics of the University of Trento, also affiliated with the Interdepartmental Center for Mind/Brain Sciences (CIMEC). He holds a PhD in Electrical and Computer Engineering from the University of Naples Federico II and conducted postdoctoral research at the University of Illinois and UC San Diego. He has held academic positions at The Ohio State University, TIGEM in Naples, and the Microsoft Research-COSBI Centre. His research focuses on computational methods for biomarker discovery, systems biology, and gene regulatory network analysis. Lauria has coordinated multiple EU and industry-funded projects, including work on metabolic markers of pre-diabetes and systems biology approaches to neurodegenerative diseases. Education: PhD in Electrical and Computer Engineering, University of Naples Federico II (1997) M.S. in Computer Science, University of Illinois at Urbana-Champaign (1996) Laurea in Electrical Engineering, University of Naples Federico II (1992) Research interests emphasize bioinformatics , systems biology , and high-performance computing , with applications to gene regulatory networks, diagnostic biomarkers, and multi-omics data integration. His work bridges computational methods with biological systems, particularly in aging, neurodegenerative diseases, and metabolic disorders. Publications reflect a focus on Alzheimer’s biomarkers , diabetes , and gene network analysis . Key contributions include rank-based biomarker algorithms and consensus clustering methods for metabolic profiles. His interdisciplinary approach spans computational tools (e.g., SCUDO, rScudo) and collaborative projects with pharmaceutical and academic partners. Awards include the 2012 SBV IMPROVER Challenge win and IEEE Senior Membership. He serves on editorial boards for journals like IEEE Transactions on Parallel and Distributed Systems and BMC Bioinformatics . Grants and collaborations include leadership in the EarlyBird pre-diabetes project and contributions to EU-funded initiatives like AnEUploidy . His academic service roles include coordinating the Data Science and Quantitative Biology master’s programs at Trento University. Labs/Teams: Active in the Microsoft Research-COSBI Centre for systems biology and the CIMEC interdisciplinary neuroscience hub.

Carlos CoView profile

Associate Professor

• Biomaterials Engineering
• Cell Biology
• Polymer Chemistry
• +3 more

Carlos Co is an Associate Professor in the Department of Chemical and Materials Engineering at the University of Cincinnati, College of Engineering. He holds academic positions since 2000, including postdoctoral fellowships and research roles at institutions like Unilever Research and Wright-Patterson Air Force Base. His research focuses on biomaterials engineering, cell migration dynamics, and complex fluid systems. Co has received prestigious awards such as the NSF CAREER Award (2007) and multiple teaching excellence recognitions. Education: Ph.D. in Chemical Engineering from the University of Delaware (2000); B.S. in Chemical Engineering & Chemistry from the University of British Columbia (1995). Key research areas include directed cell assembly, microarray engineering, and polymer vesicle synthesis. His work bridges materials science and biomedical applications, emphasizing cell-biomaterial interactions. Research interests span biomaterials design, interfacial polymerization, and microfluidic systems. Recent articles highlight advancements in cell migration steering, microarray patterning, and polymer vesicle formation. Grants include major NSF awards for studies on complex fluids and biomaterials. Notable awards include the 2009 Champion Educator Medal and BP Amoco Faculty awards. His lab develops innovative methods for cell sorting, tissue engineering, and microfiltration membrane design. Students supervised include doctoral candidates Feng Gao and Dan Wu.

Ashis MondalView profile

Assistant Professor

• Molecular Biology
• Clinical Molecular Diagnostics
• Biomarker Discovery
• +7 more

Ashis Mondal is an Assistant Professor in the Department of Pathology at the Medical College of Georgia, Augusta University. His work bridges clinical molecular diagnostics and academic research, with a strong focus on developing and validating molecular tests for patient care. His research interests include: Discovery of biomarkers in hematological malignancies and solid tumors Development and clinical validation of molecular/genetic assays Applications of molecular biology in diagnostics Genetics and gene regulation Quality assurance in molecular testing His recent publications in 2022 reflect expertise in advanced genomic technologies such as optical genome mapping, multiplex PCR, and microbiome analysis, applied to conditions including COVID-19, reproductive genetics, and colorectal cancer. These works highlight a strong trend in translational research, integrating molecular diagnostics with clinical outcomes. Selected honors and training include: PGDx elio™ tissue complete - RUO Theory & Laboratory Application Training (Personal Genome Diagnostics Inc., 2021) Graduate Aptitude Test in Engineering (GATE), 1994 State Level Eligibility Test for Lectureship (SLET), 1994 He actively contributes to education by teaching CLSC 7900: Clinical Molecular Methods Internship for MHS-CLS students and providing instruction to pathology residents and medical students. He also serves on Ph.D. advisory committees within the Department of Interdisciplinary Health Sciences, demonstrating commitment to graduate training and academic service.

Julie BourbeillonView profile

Lecturer

• Bioinformatics
• Systems Biology
• Artificial Intelligence
• +9 more

Julie Bourbeillon is a Lecturer in Computer Science at Institut Agro Rennes-Angers , where she co-directs the Department of Statistics and Computer Science. Her work bridges Bioinformatics , Computer Vision , and Data Integration with applications in Plant Biology and Horticulture . She has developed educational frameworks for integrating digital skills into horticultural training using the PiX framework . Education : PhD in Computer Science (2007, Université Grenoble 1), Master of Science and Engineering for Health and Medicine (2004), Engineer (2002, INAPG) Her research focuses on semantic distance , heterogeneous data integration , and data visualization for biological datasets. She leads the DIVIS project for handling complex phenotypic data and co-developed ELVIS and QuaDS software tools. Key projects include: DIGITOM (2024-2027): Digital twins for climate-resilient agriculture ERICA (2025-2026): Robotic climate mapping in greenhouses GRIOTE (2014-2018): Bioinformatics collaboration